David Vanderstraeten advises and represents Belgian and foreign companies on all aspects of corporate law, with a focus on M&A, private equity, and venture capital transactions. He also advises clients on corporate restructurings and reorganizations and corporate governance.
Recent key representations include the acquisition of HistoGeneX and Caprion Biosciences by Arsenal Capital Partners, the Series B financing rounds of Cowboy SA and Proxyclick SA, and HRH Prince Abdullah's acquisition of Belgian football club Beerschot.
David recently advised other major companies including Cardinal Health, Hexagon, JF Lehman, Mitsui Chemicals, PolyOne, and Riverside.
- The London School of Economics and Political Science (LL.M. 2015); University of Ghent (J.D. magna cum laude 2014); University of Santa Clara (U.S. exchange program, 2012)
- Brussels Bar
- Dutch, English, and French